Do therapies for depression improve survival and reduce morbidity in depressed CAD patients?
While depression is linked to adverse outcomes in CAD, there is currently insufficient evidence that treating depression improves clinical outcomes, highlighting the need for randomized trials.
There is substantial evidence for a relationship between depression and adverse clinical outcomes. However, despite the availability of effective therapies for depression, there is a paucity of data to support the efficacy of these interventions to improve clinical outcomes for depressed CAD patients. Randomized clinical trials are needed to further evaluate the value of treating depression in CAD patients to improve survival and reduce morbidity.
Heather S. Lett (Sat,) studied this question.